Vitoss BiModal Bioactive Bone Graft Substitute Foam Strip; Vitoss BiModal Bioactive Bone Graft Substitute; Vitoss BBTrauma Bioactive Bone Graft Substitute; Vitoss BA2X Bioactive Bone Graft Substitute; Vitoss Bioactive Foam Bone Graft Substitute Pack; Vitoss Bioactive Foam Bone Graft Substitute; Vitoss Foam Bone Graft Substitute; Vitoss Bone Graft Substitute Filled Canister; Vitoss Bone Graft Substitute
Stryker Spine · Decision date Apr 24, 2026
What did the FDA decide?
FDA records K261008 as a 510(k) premarket notification, with a decision dated Apr 24, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Apr 24, 2026
Regulatory record facts
- Identifier
- K261008
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Stryker Spine
- Product code
- MQV
- Decision code
- SESE
- Decision date
- Apr 24, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Filler, Bone Void, Calcium Compound.
- Applicant
- Stryker Spine
- Product code
- MQV
- FDA device class
- 2
FDA decision timeline
K261008 received
Application receipt date recorded by FDA.
K261008 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MQV
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
PearlBone Putty 1600K260496 | Marine Biomedical | 510(k) clearance | Nov 2, 2026 | FDA |
Mg OSTEOREVIVE;Mg OSTEOCRETEK262230 | Bone Solutions, Inc. | 510(k) clearance | Sep 11, 2026 | FDA |
Device 300419 StripK260364 | Geistlich Pharma AG | 510(k) clearance | Jun 2, 2026 | FDA |
| Sdip Innovations Pty, Ltd. | 510(k) clearance | May 26, 2026 | FDA | |
AdaptosFuse Bone GraftK253524 | Biomendex OY | 510(k) clearance | Feb 17, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Stryker Spine
- Headquarters
- Not reported
- Brand website
- stryker.com
- FDA applicant address
- Allendale, NJ
Sources and methodology
- Original FDA record: K261008
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


